SAFETY ANALYSIS OF LONG-TERM ROMIPLOSTIM USE IN PATIENTS WITH CHRONIC IMMUNE THROMBOCYTOPENIA (ITP)

被引:0
|
作者
Rodeghiero, F. [1 ]
Provan, D. [2 ]
Cines, D. [3 ]
Stasi, R. [4 ]
Tarantino, M. [5 ]
Nie, K. [6 ]
Jun, S. [6 ]
机构
[1] Dept Cell Therapy & Hematol, Vicenza, Italy
[2] Royal London Hosp, Ctr Haematol, London E1 1BB, England
[3] Dept Pathol & Lab Med, Philadelphia, PA USA
[4] St George Hosp, Dept Haematol, London, England
[5] Univ Illinois, Coll Med, Peoria, IL 61656 USA
[6] Amgen Inc, Thousand Oaks, CA 91320 USA
来源
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
0184
引用
收藏
页码:73 / 74
页数:2
相关论文
共 50 条
  • [1] Long-Term Safety Profile of Romiplostim in Patients with Chronic Immune Thrombocytopenia (ITP)
    Liebman, Howard
    Henry, David
    Lefrere, Francois
    Viallard, Jean-Francois
    Lichtin, Alan
    George, James
    Sanz, Miguel
    Zhang, Kathy
    Rutstein, Mark
    BLOOD, 2008, 112 (11) : 1171 - 1171
  • [2] Integrated Analysis of Long Term Safety in Patients (pts) with Chronic Immune Thrombocytopenia (ITP) Treated with Romiplostim
    Cines, Douglas B.
    Gernsheimer, Terry B.
    Wasser, Jeffrey
    Godeau, Bertrand
    Provan, Andrew
    Lyons, Roger M.
    Altomare, Ivy
    Wang, Xuena
    Woodard, Paul
    BLOOD, 2012, 120 (21)
  • [3] Evaluation of bleeding and thrombotic events during long-term use of romiplostim in patients with chronic immune thrombocytopenia (ITP)
    Gernsheimer, T. B.
    George, J. N.
    Aledort, L. M.
    Tarantino, M. D.
    Sunkara, U.
    Guo, D. Matthew
    Nichol, J. L.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2010, 8 (06) : 1372 - 1382
  • [4] Long-term treatment with romiplostim in patients with chronic immune thrombocytopenia: safety and efficacy
    Kuter, David J.
    Bussel, James B.
    Newland, Adrian
    Baker, Ross I.
    Lyons, Roger M.
    Wasser, Jeffrey
    Viallard, Jean-Francois
    Macik, Gail
    Rummel, Mathias
    Nie, Kun
    Jun, Susie
    BRITISH JOURNAL OF HAEMATOLOGY, 2013, 161 (03) : 411 - 423
  • [5] Long-Term Use of the Thrombopoietin-Mimetic Romiplostim in Children With Severe Chronic Immune Thrombocytopenia (ITP)
    Bussel, James B.
    Hsieh, Loan
    Buchanan, George R.
    Stine, Kimo
    Kalpatthi, Ram
    Gnarra, David J.
    Ho, Richard H.
    Nie, Kun
    Eisen, Melissa
    PEDIATRIC BLOOD & CANCER, 2015, 62 (02) : 208 - 213
  • [6] Safety and efficacy of long-term treatment with romiplostim in thrombocytopenic patients with chronic ITP
    Bussel, James B.
    Kuter, David J.
    Pullarkat, Vinod
    Lyons, Roger M.
    Guo, Matthew
    Nichol, Janet L.
    BLOOD, 2009, 113 (10) : 2161 - 2171
  • [7] Safety and Efficacy Of Long-Term Open-Label Romiplostim Dosing In Thrombocytopenic Pediatric Patients With Immune Thrombocytopenia (ITP)
    Tarantino, Michael D.
    Bussel, James B.
    Geddis, Amy
    Guerrera, Michael F.
    Ikeda, Alan K.
    Nie, Kun
    Eisen, Melissa
    BLOOD, 2013, 122 (21)
  • [8] Integrated analysis of long-term safety in patients with chronic immune thrombocytopaenia (ITP) treated with the thrombopoietin (TPO) receptor agonist romiplostim
    Douglas B. Cines
    Terry Gernsheimer
    Jeffrey Wasser
    Bertrand Godeau
    Drew Provan
    Roger Lyons
    Ivy Altomare
    Xuena Wang
    Angela Lopez
    International Journal of Hematology, 2015, 102 : 259 - 270
  • [9] Integrated analysis of long-term safety in patients with chronic immune thrombocytopaenia (ITP) treated with the thrombopoietin (TPO) receptor agonist romiplostim
    Cines, Douglas B.
    Gernsheimer, Terry
    Wasser, Jeffrey
    Godeau, Bertrand
    Provan, Drew
    Lyons, Roger
    Altomare, Ivy
    Wang, Xuena
    Lopez, Angela
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2015, 102 (03) : 259 - 270
  • [10] Home Administration of Romiplostim by Patients with Chronic Immune Thrombocytopenia (ITP).
    Lyons, Roger M.
    Boccia, Ralph V.
    Macik, Gail
    Mandanas, Romeo A.
    Wang, Xuena
    Lizambri, Richard
    Berger, Dietmar
    BLOOD, 2009, 114 (22) : 1362 - 1362